Similar documents
Terminology. Metabolite: substance produced or used during metabolism such as lipids, sugars and amino acids

Metabolomics: quantifying the phenotype

Supplementary Information. Effects of Perfluorooctanoic Acid on Metabolic Profiles in Brain and Liver of Mouse by a

Terminology. Metabolite: substance produced or used during metabolism such as lipids, sugars and amino acids

Analytical Developments for Identification and Authentication of Botanicals

Metabolomics in the identification of biomarkers of dietary intake

2. Selection criteria for substances of herbal origin relevant for standardization and quality control of herbal medicines 77

Small Molecule Science: Experimental designs for achieving ultra trace analysis

SZ Tan ST4 Ophthalmology MREH

Urinary metabolic profiling in inflammatory bowel disease. Dr Horace Williams Clinical Research Fellow Imperial College London

Chapter 1. Introduction

Metabolite: substance produced or used during metabolism such as lipids, sugars and amino acids

Glycerolipid Analysis. LC/MS/MS Analytical Services

Metabolomics A New Tool in Molecular Toxicology

Clinical Metabolomics: The Trials of Investigating Metabolic Effects on Human Volunteers

Choosing the metabolomics platform

Metabolite identification in metabolomics: Database and interpretation of MSMS spectra

Metabolomic fingerprinting of serum samples by direct infusion mass spectrometry

Life Science and Chemical Analysis Solutions. Baljit Ubhi, Jeff Patrick, David Alonso, and Joe Shambaugh 1 2 3

BIOCRATES Life Sciences AG

Metabolite identification in metabolomics: Metlin Database and interpretation of MSMS spectra

USP Dietary Supplements Standards Up-to-Date Roundtable Meeting Report. Huy Dinh, MS. Senior Scientific Liaison Dietary Supplements

MALDI Imaging Drug Imaging Detlev Suckau Head of R&D MALDI Bruker Daltonik GmbH. December 19,

INFLUENCE OF EARLY NUTRITION ON METABOLIC PROCESSES

Ultra Performance Liquid Chromatography Coupled to Orthogonal Quadrupole TOF MS(MS) for Metabolite Identification

Metabonomics and MRS BCMB/CHEM 8190

Quality Control of Herbal Products. Dr. Fabio Boylan

Savesta Herbals is engaged in manufacturing

Simple Cancer Screening Based on Urinary Metabolite Analysis

Gut microflora and estrogens: a new paradigm for breast cancer risk reduction. Dr. Kathleen Egan (Moffitt) Dr. Lusine Yaghjyan (UF)

Development of a simple method for nicotine determination in mushrooms

Metabolomics and systems biology approaches to study health and disease. Matej Oreši

Annamária Jakab. Supervisor: Eszter Forgács

CONTENT. i iv ix. SVKM s NMIMS, School of Pharmacy and Technology Management

James Grech. Bachelor of Medical Science (UC) National Centre for Forensic Studies (NCFS) University of Canberra, ACT 2601

numares at a glance company overview 2014 Discover, understand and use biological systems high level NMR analytics

Mass Spectrometry based metabolomics

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

A UPLC/MS Approach for the Diagnosis of Inborn Errors of Metabolism

CranLoad Sport. Novel formula for high intensity sports performance and endothelial function*

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

MASS SPECTROMETRY BASED METABOLOMICS. Pavel Aronov. ABRF2010 Metabolomics Research Group March 21, 2010

CHAPTER 8 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) ANALYSIS OF PHYTOCHEMICAL CONSTITUENTS OF M. ROXBURGHIANUS AND P. FRATERNUS PLANT EXTRACTS

Antioxidants & Detoxification

NMR for Metabolomics


Digitizing the Proteomes From Big Tissue Biobanks

Computer assisted identification of green tea metabolites in human urine. Lars Ridder ICCS, Noordwijkerhout 2014

A New Method for the Early Detection of Edible Oil Oxidation

DiscovIR-LC. Application Note 026 May 2008 READING TEA LEAVES SUMMARY INTRODUCTION

Detection of Lipid Peroxidation Products From Free Radical and Enzymatic Processes. Jason D. Morrow M.D. Vanderbilt University School of Medicine

The use of mass spectrometry in lipidomics. Outlines

Mass Spectrometry Infrastructure

MASS SPECTROMETRY IN METABOLOMICS

A Definitive Lipidomics Workflow for Human Plasma Utilizing Off-line Enrichment and Class Specific Separation of Phospholipids

CHAPTER 6. Conclusions and Perspectives

Simultaneous, rapid and sensitive quantification of 8-hydroxy-2'-deoxyguanosine and cotinine in human urine

Challenges in Mass Spectrometry Based Non-Targeted Analysis

An Alternative Approach: Top-Down Bioanalysis of Intact Large Molecules Can this be part of the future? Lecture 8, Page 27

Biomarkers for gut comfort

This annex is valid from: to Replaces annex dated: Location(s) where activities are performed under accreditation

Value chains of herbal medicines: Cases studies on Jiang huang (Curcuma longa and Hong jingtian (Rhodiola Spp)

Chapter 10. Summary and Conclusions

QUALITY OF HERBAL REMEDIES

Risk Assessment of NIAS in Food Contact Adhesives

METABOLOMIC INVESTIGATION OF ALCOHOL-INDUCED FATTY LIVER A THESIS SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY

Elise Cook. BForensics (Hons) Forensic Biology and Toxicology. BSc Biomedical Science and Molecular Biology

Drug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee

High resolution mass spectrometry for bioanalysis at Janssen. Current experiences and future perspectives

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe

Hystory and Coordination activities

Chapter 4 SUMMARY AND CONCLUSION

Million B. Woudneh, M. Coreen Hamilton, Jonathan P. Benskin, Guanghui Wang, John R. Cosgrove SETAC, Nashville November 2013

PHOSPHOCOMPLEX. Silybin-Phosphatidylcholine Complex TITOLO PRESENTAZIONE

Drying, Juices and Jams of Organic Fruit and Vegetables: what happens to Desired and Non- Desired compounds? FAVORDENONDE

Éva Sedlák. Pharmaceutical Sciences Doctoral School Semmelweis University. PhD thesis. Supervisors: Dr. István Gyurján D.Sc. Dr. Béla Böddi D.Sc.

Nuclear Magnetic Resonance (NMR) Spectroscopy

Occupational exposure to alcohol-based hand sanitizers: the diriment role of alcohol biomarkers in hair

Low-level environmental phthalate exposure associates with urine metabolome. alteration in a Chinese male cohort

PRAKRUTI PRODUCTS PVT LTD

Determination of Aspirin Tablet Manufacturers by an NMR-based Metabolomic Approach

Authenticity Panel Authenticated materials to be used in the validation study for identity.

Workshop on Non-Target Screening Towards the harmonisation of methods for non-target screening of environmental samples

Proteomics of body liquids as a source for potential methods for medical diagnostics Prof. Dr. Evgeny Nikolaev

Summary 255 Research Summary

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: March 1, Related Policies None

Polymer Additive Analysis by EI and APCI

LC/MS/MS SOLUTIONS FOR LIPIDOMICS. Biomarker and Omics Solutions FOR DISCOVERY AND TARGETED LIPIDOMICS

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:

Procedure for Toxicology Analysis Version 7 Toxicology Unit Effective Date: 03/14/2014 Issued by Drug Chemistry Forensic Scientist Manager

Optimization of extraction method and profiling of plant phenolic compounds through RP-HPLC

Storage Experiments of Extra Virgin Olive Oils from the Discounter

Probing the water flea's biochemistry: a truly complex but high information content environmental sample

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: October 1, Related Policies None

CHARACTERIZATION AND DETECTION OF OLIVE OIL ADULTERATIONS USING CHEMOMETRICS

Metabolomics Workshop May 8-11, Workshop goal: To build a solid foundation for participants to expand their research using metabolomics.

Medical Policy Outpatient Drug Screening and Testing. No Prior Authorization X X

Method Validation for the Analysis of Multiple Weight Loss Drugs in Dietary Supplement Materials by LC-MS/MS

Toxicological risk assessment of Aristolochia species. Johanna Michl

Payment Policy Drug Testing EFFECTIVE DATE: POLICY LAST UPDATED:

Transcription:

PhD student Gregorio Peron e-mail: gregorio.peron@studenti.unipd.it tel.: 347 4802865 Proposed supervisor Dott. Stefano Dall Acqua e-mail: stefano.dallacqua@unipd.it tel.: 049 8275332 Project title English: Antioxidant activity evaluation of phytochemicals in animal models through an innovative metabolomic approach Italian: Studio dell attività antiossidante di fitocomposti in modelli animali mediante un innovativo approccio metabolomico 1. State of the art In the recent years the consumers demand of both food and non-food products intended for the prevention of diseases, or for well-being, has increased. Most of these products, sold both in the form of pharmaceuticals or food supplements, are of natural origin. These are usually defined nutraceuticals, because they derived from food sources that are purported to provide extra health benefits, in addition to their nutritional value. Various epidemiological studies have related regular intake of vegetables with the lower incidence of age-related diseases and cancer. This protective effect has been attributed to specific classes of natural compounds (called phytochemicals), which can exhibit antioxidant properties that contribute to protect the body from oxidative stress. Nevertheless, the biochemical mechanisms underlying their beneficial activities have not been well defined yet, due to the multi targeting nature of these natural products as well as due to the complexity of their chemical structures and to the difficulties of studying the antioxidant activity in vivo. An emerging field of research is metabolomics, that is concerned with the high-throughput identification and quantification of small molecule (<1500 Da) in the metabolome and provides a useful systemic approach to observe changes in animals or humans metabolome in response to 1

pharmaceutic, nutritional, genetics and environment stimuli. Metabolic fingerprinting is a complex matrix profiling strategy which can be applied to a variety of sample matrices like biofluids (e.g. tissue extracts, urine, plasma). The variety of metabolomic fingerprinting strategies has increased in recent years: example techniques have included nuclear magnetic resonance (NMR), high-pressure liquid chromatography mass spectrometry (HPLC-MS) and gas chromatography mass spectrometry (GC-MS), coupled with multivariate data analysis to explore and interpret complex spectroscopic data derived from biofluid or tissue samples. 2. Objectives and expected results Phytochemicals and plant extracts are widely used as health-promoters, especially the ones showing antioxidant and anti-aging properties. Nevertheless studies related to their real in vivo antioxidant activities as well as on their effects on healthy subjects are still lacking. The aim of the research project here described is to evaluate the effect of the administration of natural extracts in animal models (i.e. rats) by the metabolomic approach. First, plant extracts will be selected on the basis of previously known antioxidant and antiinflammatory activities. As example some of the extracts that will be considered will be Curcuma longa, Vitis vinifera, Vaccinium macrocarpon, Boswellia serrata and Commiphora mhyrra. Such extracts due to their phytochemical composition possess different antioxidant properties that are considered important for their health promoting activity. For this reason accurate phytochemical characterization of the selected plant extracts will be performed in the first part of the project in order to establish the amount of potentially active phytoconstituents (curcumin, resveratrol, etc). Each extract will be analyzed from a quali-quantitative point of view to determine the exact amount of phytochemicals present using the more appropriate analytical technique. Later, established quantities of standardized herbal extracts will be administered daily to healthy animals, for predefined periods of time. These amounts will simulate the quali-quantitative compositions of nutraceuticals on the market, so as to verify the long-term health-promoting usefulness in healthy in vivo models. The first goals will be the evaluation of metabolic changes in urine of healthy rats treated with different types of natural antioxidants and the creation and comparison of metabolomic datasets for 2

the different phytochemicals studied. Variations in the amount of urinary metabolites will be compared with the control group (rats to which no extracts are administered). Targeted analysis will be also performed in order to measure specific metabolites such as urinary markers of oxidative stress. Analysis of faecal samples with attention to bile acid and short chain fatty acids will be also performed in order to establish potential relationships of the intake of phytochemicals and intestinal microbiota. Plasma samples will be collected at the end of the experiments in order to measure plasma GSH and GSSG levels. The results above will be the starting point for the third goal of the project, which will be the search for possible biomarkers useful for the evaluation of the antioxidant effect of specific classes of compounds studied. 3. Methods First of all, each standardized extract will be analyzed under a quali-quantitative point of view to determine the amount of each antioxidant. The qualitative analysis will be performed by the more appropriate analytical technique considering the phytochemical composition. Quali-quantitative phytochemical profiles will be in general obtained by HPLC-MS and GC-MS. The animal experiments will be performed with the different antioxidants extracts using rats as in vivo models. The rats will be divided in multiple groups, each of which will be treated with the different extracts studied. Groups receiving no supplementation as negative control will also be used. Urine will be collected using metabolic cages and it will be divided in three equal amounts, which will be analyzed by 1 H-NMR, LC-MS and GC-MS to create the metabolomic datasets. These techniques will allow the observation of different analytical patterns leading to a more complete observation of the metaboloma. Different analysis conditions for the chromatographic techniques will be established on the basis of the analyzed compound. The raw data will be transformed in matrices that will be used to make a statistical comparison to identify the relevant spectral features that distinguish sample classes. A multivariate statistical analysis (PCA, PLS-DA, etc) will be applied on both NMR data and MS data. In each case, as results of statistical analysis, a set of signals responsible of the separation of the sample will be found and the next work will be concentrated on the identification of the metabolites that originated these signals. Exploiting MS/MS fragmentation it will be possible to investigate the structure of the 3

metabolites detected. Analysis for the identification of unmodified antioxidant in the samples will be also performed. 4. Workplan During the first year of the research project the characterization of the selected extracts will be performed to determine the amounts of potentially active phytocompounds. Later, the extracts will be administered to small groups of healthy rats, in such quantities as to simulate a regular intake of nutraceuticals in humans. Metabolomic profiles of both treated and untreated in vivo models will be created from the analysis of biological samples. Much of the work will be then dedicated to the interpretation and statistical analysis of the spectral results obtained, from which shall be identified specific signals that can be attributed to different in vivo effects of the various antioxidants studied. During the beginning of the second year the work will be focused on the molecular characterization of the most relevant metabolites identified. Based on the results obtained, the entire in vivo study will be repeated by changing the dose of phytochemicals administered to healthy rats and comparing the metabolomic profiles obtained with the previous ones. During the last year of the project, the study of antioxidant activity of the extracts whose beneficial effects on healthy subjects were demonstrated may be extended to a larger number of animal subjects. In addition, the specific antioxidants may be tested in non-healthy animal models in which oxidative stress will be induced, in order to assess the effects of specific antioxidant phytochemicals in disease patterns and create new metabolic datasets. 5. Relevant references Kelsey NA, Wilkins HM, Linseman DA. Nutraceutical antioxidants as novel neuroprotective agents. Molecules, 2010; 15 (11): 7792-814. Fardet A et al. Metabolomics provide new insight on the metabolism of dietary phytochemicals in rats. J Nutr, 2008; 138 (7): 1282-7. An D, Zhang Q, Wu S, Wei J, Yang J, Dong F, Yan X, Guo C. Changes of metabolic profiles in urine after oral administration of quercetin in rats. Food Chem Toxicol, 2010; 48 (6): 1521-7. 4

Dall'Acqua S, Stocchero M, Clauser M, Boschiero I, Ndoum E, Schiavon M, Mammi S, Schievano E. Changes in urinary metabolic profile after oral administration of curcuma extract in rats. J Pharm Biomed Anal, 2014; 100: 348-56. 5